- Home
- FDMT vs LTBR Comparison
FDMT vs LTBR Comparison
Compare FDMT & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | LTBR |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 575.6M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FDMT | LTBR |
|---|---|---|
| Price | $8.83 | $11.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $31.71 | N/A |
| AVG Volume (30 Days) | 652.3K | ★ 755.4K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $70.28 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $3.03 | $8.85 |
| 52 Week High | $12.34 | $31.34 |
Technical Indicators
Market Signals| Indicator | FDMT | LTBR |
|---|---|---|
| Relative Strength Index (RSI) | 40.43 | 44.57 |
| Support Level | $8.25 | $11.00 |
| Resistance Level | $10.70 | $11.53 |
| Average True Range (ATR) | 0.49 | 0.96 |
| MACD | -0.14 | 0.04 |
| Stochastic Oscillator | 4.95 | 21.87 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.